|tenofovir prodrugs gs4370 and TAF
Mar 30, 2013
can you give me an idea of when hiv patients will be able to access the tenofovir prodrugs in development. Can you tell me how I can participate in one of their studies (Merke, Gillead)?
| Response from Dr. Young
Hello and thanks for posting.
GS7340/TAF is a new prodrug of tenofovir that is in clinical trials. Encouraging phase 2 clinical trials data on TAF was presented recently at the CROI conference, suggesting improved potency and toxicity profiles.
TAF is only available in clinical trials at this point. You can search clinicaltrials.gov to check on the status of ongoing trials. Since the phase 3 clinical trials are underway, if successful, I'd expect FDA review for the new drug application within the next 2 years.
I hope that helps, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.